Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Jun;37(6):1554-62.
doi: 10.2337/dc13-1904.

Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children

Affiliations
Comparative Study

Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children

Fergus J Cameron et al. Diabetes Care. 2014 Jun.

Abstract

Objective: To investigate the impact of new-onset diabetic ketoacidosis (DKA) during childhood on brain morphology and function.

Research design and methods: Patients aged 6-18 years with and without DKA at diagnosis were studied at four time points: <48 h, 5 days, 28 days, and 6 months postdiagnosis. Patients underwent magnetic resonance imaging (MRI) and spectroscopy with cognitive assessment at each time point. Relationships between clinical characteristics at presentation and MRI and neurologic outcomes were examined using multiple linear regression, repeated-measures, and ANCOVA analyses.

Results: Thirty-six DKA and 59 non-DKA patients were recruited between 2004 and 2009. With DKA, cerebral white matter showed the greatest alterations with increased total white matter volume and higher mean diffusivity in the frontal, temporal, and parietal white matter. Total white matter volume decreased over the first 6 months. For gray matter in DKA patients, total volume was lower at baseline and increased over 6 months. Lower levels of N-acetylaspartate were noted at baseline in the frontal gray matter and basal ganglia. Mental state scores were lower at baseline and at 5 days. Of note, although changes in total and regional brain volumes over the first 5 days resolved, they were associated with poorer delayed memory recall and poorer sustained and divided attention at 6 months. Age at time of presentation and pH level were predictors of neuroimaging and functional outcomes.

Conclusions: DKA at type 1 diabetes diagnosis results in morphologic and functional brain changes. These changes are associated with adverse neurocognitive outcomes in the medium term.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Group differences (DKA vs. non-DKA) for TBVs. Data are presented as the estimated mean and 95% CI at each time point. A: Total supratentorial brain volumes. B: Total supratentorial white matter volume. C: Total supratentorial gray matter volume; *P = 0.014. D: Total cortical white matter volume/TBV; *P = 0.008. E: Total cortical gray matter volume/TBV; *P = 0.008.
Figure 2
Figure 2
Group differences (DKA vs. non-DKA) for frontal lobe volumes, diffusivity, and spectroscopy. Data are presented as the estimated mean and 95% CI at each time point. A: Frontal lobe white matter relative volume; *P = 0.002. B: Frontal lobe white matter diffusivity; *P < 0.001. C: Frontal lobe white matter NAA spectroscopy; *P = 0.005. D: Frontal lobe gray matter relative volume. E: Frontal lobe gray matter diffusivity; *P = 0.013. F: Frontal lobe gray matter NAA spectroscopy; *P = 0.005.
Figure 3
Figure 3
Group differences (DKA vs. non-DKA) for cognitive outcomes. Data are presented as the estimated mean and 95% CI at each time point. A: Mental state (SYSTEMS) score; *P = 0.002. B: Delayed memory raw score; *P = 0.002. C: Focused attention (Sky Search) scaled score. D: Dual-modality divided attention (Sky Search DT) scaled score. E: Single-modality divided attention (Score DT) scaled score. F: Sustained attention/impulsivity (Walk/Don’t Walk) scaled score. DT, dual task.

References

    1. Craig ME, Hattersley A, Donaghue KC. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes 2009;10(Suppl. 12):3–12 - PubMed
    1. McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet 2012;379:2291–2299 - PubMed
    1. Marcin JP, Glaser N, Barnett P, et al. American Academy of Pediatrics; The Pediatric Emergency Medicine Collaborative Research Committee Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema. J Pediatr 2002;141:793–797 - PubMed
    1. Wolfsdorf J, Craig ME, Daneman D, et al. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr Diabetes 2009;10(Suppl. 12):118–133 - PubMed
    1. Edge JA, Jakes RW, Roy Y, et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia 2006;49:2002–2009 - PubMed

Publication types